🇬🇧·Oct 1, 2024CDMO
CEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck Cancer
Publisher
E
Ergomed
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Ergomed
- Region
- UK
- Scope
- CDMO
- Published
- October 1, 2024
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ergomedgroup.com
Leave the platform to read the original full article on the publisher site.
Source: Ergomed
Scope: CDMO
Related coverage
More related coverage
American Society of Nephrology·20h ago
New nephSAP Issue: Electrolytes and Acid-Base Disorders
University of Freiburg·20h ago
EPICUR Seed Funding 2026 – submit your project ideas now
Erasmus University Rotterdam·20h ago
Tâm Ngô appointed as endowed professor of Historical Anthropology of War Legacies
University of Freiburg·20h ago